Kane Biotech Will Present at Wound Care Symposium
The company hosts a booth and shares new clinical data this October 15-18 in Las Vegas.
Updated on Oct. 7, 2026 in Biotech
Live Poll
Do you believe healthcare companies are prioritizing patient access when expanding into new regional markets?
Kane Biotech will bring its revyve wound care product line to the Symposium on Advanced Wound Care Fall 2026, held in Las Vegas from October 15-18, 2026. The firm intends to use the conference to engage with clinicians and explore new distribution partnerships.
Why it matters
The symposium serves as a primary hub for the local and national wound-care community to review clinical findings and research. Connecting at this event supports the firm's plans to grow product awareness and commercial reach within the United States.
The company will operate from Booth #544 at the symposium, showcasing products that have already secured U.S. FDA 510(k) clearance and maintain ISO 13485:2016 certification. Details regarding the full scope of their expansion goals remain in discussion with potential partners.
The players
Kane Biotech
A company headquartered in Winnipeg, Manitoba, that produces antimicrobial wound care products.
Dr. Robert Huizinga
A researcher who will present three scientific posters regarding revyve products.
The details
At the upcoming symposium, Kane Biotech will showcase its revyve Antimicrobial Wound Gel and Spray. Dr. Robert Huizinga is scheduled to present three scientific posters on October 17, 2026. The company will also hold meetings with distribution partners to discuss future market presence and product development strategies.
Timeline
October 15-18, 2026: The Symposium on Advanced Wound Care takes place in Las Vegas.
October 17, 2026: Dr. Robert Huizinga presents three scientific posters.
Beyond the Strip
The Symposium on Advanced Wound Care remains a standard professional venue for biotech firms to validate their products with clinical data. Kane Biotech's participation follows a pattern where companies leverage this specific conference to bridge the gap between regulatory approval and market adoption.
Local medical professionals and researchers can engage directly with the company at their exhibit booth during the event dates. Attendees should note that specific clinical presentations are scheduled to take place on October 17.
The takeaway
Kane Biotech's participation highlights the company's push for U.S. commercial expansion following recent regulatory milestones. Watch for the presentation of clinical data on October 17 to gauge the performance of their antimicrobial gel line.
Further reading
For more news on regional medical research and technology, check the Biotech section.
Live Poll
Do you believe healthcare companies are prioritizing patient access when expanding into new regional markets?
